[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

GLOBAL STEM CELL MARKET FORECAST 2017-2025

July 2017 | 132 pages | ID: G4F956D1216EN
Inkwood Research

US$ 2,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
KEY FINDINGS

The global market for stem cell is anticipated to expand at a CAGR of 9.68% during the forecast period of 2017-2025. The rise in neurodegenerative diseases is the primary factor for the growth of the stem cell market.

MARKET INSIGHTS

The global stem cell market is segmented on the basis of product, technology, application, and geography. The stem cell market of the product is segmented into adult stem cell, embryonic stem cell, induced pluripotent stem cell market and rat neutral stem cell market. The stem cell market of technology is segmented into stem cell acquisition market, stem cell production market, stem cell cryopreservation market and stem cells expansion and sub-culture market. The application of the stem cell market is segmented into stem cells regenerative medicine market and drug discovery and development market. The stem cell market geography is segmented into North America, Europe, Asia-Pacific and rest of the world. the upsurge in neurodegenerative ailments, growing investments in R&D, government subsidy and sustenance, advancements in the applications of stem cell, significant growth in medical tourism, swelling stem cell banking are the major drivers for the stem cell market.

REGIONAL INSIGHTS

The Stem Cell market in North America is expected to hold the largest share by 2025. Increased investments in research and development activities for the stem cell market and the presence of popular pharmaceutical market have contributed to the growth of the US market in the North American region. Asia- Pacific is anticipated to grow at CAGR of 26.23%, the fastest growing region among others. The growth of Asia-Pacific region is primarily driven due to growing incidences of chronic lifestyle diseases and government supports and their initiatives. Europe has generated revenue of $13556 million in 2016 which is set to increase by 2025. The Europe stem cell analysis market is primarily driven by the rising prevalence of chronic disorders such as cancer and cardiovascular disorders.

COMPETITIVE INSIGHTS

The market players in the stem cell market are Cytori therapeutics Inc., Fibrocell science, Cellartis AB (acquired by Takara holdings Inc.), Biotime Inc., GE Healthcare, Thermo fisher scientific Pvt Ltd, Stem cell technologies, Cellular dynamics international (holding company Fujifilm), Vericel corporation (Aastrom bioscience), Brainstorm cell therapeutics, California stem cell Inc. (Holding company Caladrius biosciences, Inc. ), Beckton Dickinson and company, Stryker corporation, Celgene corporation. Some major companies involved in stem cell are; GE Healthcare, Stem cell technology, Thermo Fisher, Becton, Corning and many others.
1. RESEARCH SCOPE

1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

2.1. SOURCES OF DATA
  2.1.1. SECONDARY DATA
  2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
2.5. ESTIMATION METHODOLOGY

3. EXECUTIVE SUMMARY

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

4. MARKET DETERMINANTS

4.1. MARKET DRIVER
  4.1.1. UPSURGE IN NEURODEGENERATIVE AILMENTS
  4.1.2. INVESTMENTS IN R&D IS GROWING
  4.1.3. GOVERNMENT SUBSIDY AND SUSTENANCE
  4.1.4. ADVANCEMENTS IN THE APPLICATIONS OF STEM CELL
  4.1.5. SIGNIFICANT GROWTH IN MEDICAL TOURISM
  4.1.6. SWELLING STEM CELL BANKING
4.2. MARKET RESTRAINTS
  4.2.1. STEM CELL TREATMENT INCURS HUGE COST
  4.2.2. AVERSION IN REIMBURSEMENT POLICIES
4.3. MARKET OPPORTUNITIES
  4.3.1. RISING INVESTMENT IN THE STEM CELL MARKET
  4.3.2. REPLACED THE USE OF ANIMAL TISSUES FOR THE EXPERIMENTS
  4.3.3. GROWING INCOME OF THE PEOPLE ALL ACROSS THE WORLD
  4.3.4. CONTINUE SUPPORT OF CONTRACT RESEARCH INDUSTRY
4.4. MARKET CHALLENGES
  4.4.1. STRINGENT GOVERNMENT REGULATIONS
  4.4.2. FEWER RESPONSIVENESS IN THE DEVELOPED ECONOMIES

5. MARKET SEGMENTATION

5.1. BY PRODUCTS
  5.1.1. ADULT STEM CELL MARKET
    5.1.1.1. HEMATOPOIETIC STEM CELL MARKET
    5.1.1.2. MESENCHYMAL STEM CELL MARKET
    5.1.1.3. NEURAL STEM CELL MARKET
    5.1.1.4. DENTAL STEM CELL MARKET
    5.1.1.5. UMBILICAL CORD STEM CELL MARKET
  5.1.2. HUMAN EMBRYONIC STEM CELL
  5.1.3. INDUCED PLURIPOTENT STEM CELL MARKET
  5.1.4. RAT NEURAL STEM CELL MARKET
5.2. BY TECHNOLOGY
  5.2.1. STEM CELL ACQUISITION MARKET
    5.2.1.1. STEM CELL BONE MARROW MARKET
    5.2.1.2. STEM CELL APHERESIS MARKET
    5.2.1.3. STEM CELL UMBILICAL CORD BLOOD MARKET
  5.2.2. STEM CELL PRODUCTION MARKET
    5.2.2.1. THERAPEUTIC CLONING FOR STEM CELL MARKET
    5.2.2.2. IVF STEM CELL MARKET
    5.2.2.3. STEM CELL CULTURE MARKET
  5.2.3. STEM CELL CRYOPRESERVATION MARKET
  5.2.4. STEM CELLS EXPANSION AND SUB-CULTURE MARKET
5.3. STEM CELLS MARKET BY APPLICATION
  5.3.1. STEM CELLS REGENERATIVE MEDICINE MARKET
  5.3.2. DRUG DISCOVERY AND DEVELOPMENT MARKET

6. KEY ANALYTICS

6.1. PORTER’S FIVE FORCES ANALYSIS
  6.1.1. THREAT OF NEW ENTRANTS
  6.1.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
  6.1.3. BARGAINING POWER OF BUYER
  6.1.4. BARGAINING POWER OF SUPPLIER
  6.1.5. INTENSITY OF COMPETITIVE RIVALRY
6.2. PESTEL ANALYSIS
6.3. VALUE CHAIN ANALYSIS
6.4. OPPORTUNITY MATRIX
6.5. KEY BUYING CRITERIA
  6.5.1. HIGH PRICE
  6.5.2. EFFICANCY
  6.5.3. APPLICATION AND EFFECTIVENESS
  6.5.4. ACCURACY
6.6. STRATEGIC RECOMMENDATION & STRATEGIC CONCLUSIONS
6.7. VENDOR LANDSCAPE

7. GEOGRAPHICAL ANALYSIS

7.1. NORTH AMERICA STEM CELL MARKET
  7.1.1. UNITED STATES (U.S.) STEM CELL MARKET
  7.1.2. CANADA STEM CELL MARKET
7.2. EUROPE STEM CELL MARKET
  7.2.1. UNITED KINGDOM (UK) STEM CELL MARKET
  7.2.2. FRANCE STEM CELL MARKET
  7.2.3. GERMANY STEM CELL MARKET
  7.2.4. SPAIN STEM CELL MARKET
  7.2.5. ITALY STEM CELL MARKET
  7.2.6. ROE STEM CELL MARKET
7.3. ASIA-PACIFIC STEM CELL MARKET
  7.3.1. INDIAN STEM CELL MARKET
  7.3.2. CHINA STEM CELL MARKET
  7.3.3. JAPAN STEM CELL MARKET
  7.3.4. KOREA STEM CELL MARKET
  7.3.5. REST OF APAC STEM CELL MARKET
7.4. REST OF THE WORLD (ROW) STEM CELL MARKET
  7.4.1. LATIN AMERICA STEM CELL MARKET
  7.4.2. MENA STEM CELL MARKET
  7.4.3. AFRICA STEM CELL MARKET

8. COMPETITIVE LANDSCAPE

8.1. MARKET SHARE ANALYSIS
  8.1.1. TOP WINNING STRATEGIES

9. COMPANY PROFILE

9.1. CYTORI THERAPEUTICS INC.
  9.1.1. OVERVIEW
  9.1.2. PRODUCT PORTFOLIO
  9.1.3. SCOT ANALYSIS
  9.1.4. STRATEGIC ANALYSIS
9.2. FIBROCELL SCIENCE
  9.2.1. OVERVIEW
  9.2.2. PRODUCT PORTFOLIO
  9.2.3. STRATEGIC INITIATIVES
  9.2.4. SCOT ANALYSIS
  9.2.5. STRATEGIC ANALYSIS
9.3. CELLARTIS AB (ACQUIRED BY TAKARA HOLDINGS INC.)
  9.3.1. OVERVIEW
  9.3.2. PRODUCT PORTFOLIO
  9.3.3. STRATEGIC INITIATIVES
  9.3.4. SCOT ANALYSIS
  9.3.5. STRATEGIC ANALYSIS
9.4. BIOTIME INC.
  9.4.1. OVERVIEW
  9.4.2. PRODUCT PORTFOLIO
  9.4.3. SCOT ANALYSIS
  9.4.4. STRATEGIC ANALYSIS
9.5. GE HEALTHCARE
  9.5.1. OVERVIEW
  9.5.2. PRODUCT PORTFOLIO
  9.5.3. STRATEGIC INITIATIVES
  9.5.4. SCOT ANALYSIS
  9.5.5. STRATEGIC ANALYSIS
9.6. THERMO FISHER SCIENTIFIC PVT. LTD
  9.6.1. OVERVIEW
  9.6.2. PRODUCT PORTFOLIO
  9.6.3. STRATEGIC INITIATIVE
  9.6.4. SCOT ANALYSIS
  9.6.5. STRATEGIC ANALYSIS
9.7. STEMCELL TECHNOLOGIES
  9.7.1. OVERVIEW
  9.7.2. PRODUCT PORTFOLIO
  9.7.3. STRATEGIC INITIATIVES
  9.7.4. SCOT ANALYSIS
  9.7.5. STRATEGIC ANALYSIS
9.8. CELLULAR DYNAMICS INTERNATIONAL (HOLDING COMPANY FUJIFILM)
  9.8.1. OVERVIEW
  9.8.2. PRODUCT PORTFOLIO
  9.8.3. STRATEGIC INITIATIVES
  9.8.4. SCOT ANALYSIS
  9.8.5. STRATEGIC ANALYSIS
9.9. VERICEL CORPORATION (AASTROM BIOSCIENCE)
  9.9.1. OVERVIEW
  9.9.2. PRODUCT PORTFOLIO
  9.9.3. STRATEGIC INITIATIVES
  9.9.4. SCOT ANALYSIS
  9.9.5. STRATEGIC ANALYSIS
9.10. BRAINSTORM CELL THERAPEUTICS
  9.10.1. OVERVIEW
  9.10.2. PRODUCT PORTFOLIO
  9.10.3. SCOT ANALYSIS
  9.10.4. STRATEGIC ANALYSIS
9.11. CALIFORNIA STEM CELL INC. (HOLDING COMPANY CALADRIUS BIOSCIENCES, INC )
  9.11.1. OVERVIEW
  9.11.2. PRODUCT PORTFOLIO
  9.11.3. STRATEGICINITIATIVES
  9.11.4. SCOT ANALYSIS
  9.11.5. STRATEGICANALYSIS
9.12. BECKTON DICKINSON AND COMPANY
  9.12.1. OVERVIEW
  9.12.2. PRODUCT PORTFOLIO
  9.12.3.SCOT ANALYSIS
  9.12.4.STRATEGIC ANALYSIS
9.13. STRYKER CORPORATION
  9.13.1. OVERVIEW
  9.13.2. PRODUCTPORTFOLIO
  9.13.3. SCOT ANALYSIS
  9.13.4. STRATEGICANALYSIS
9.14. CORNING INC.
  9.14.1. OVERVIEW
  9.14.2. PRODUCT PORTFOLIO
  9.14.3. SCOT ANALYSIS
  9.14.4. STRATEGIC ANALYSIS
9.15. CELGENE CORPORATION
  9.15.1. OVERVIEW
  9.15.2. PRODUCTPORTFOLIO
  9.15.3. STRATEGIC INITIATIVES
  9.15.4. SCOT ANALYSIS
  9.15.5. STRATEGIC ANALYSIS

TABLE LIST

TABLE 1 COUNTRY WISE PERCENTAGE OF SAVINGS IN STEM CELL TREATMENT
TABLE 2 GLOBAL STEM CELLS MARKET BY PRODUCTS 2017-2025 ($ MILLION)
TABLE 3 ADULT STEM CELL MARKET BY REGION 2017-2025 ($ MILLION)
TABLE 4 ADULT STEM CELL MARKET 2017-2025 ($ MILLION)
TABLE 5 GLOBAL STEM CELL MARKET IN HEMATOPOITIC STEM CELL BY REGION 2017-2025 ($ MILLION)
TABLE 6 GLOBAL STEM CELL MARKET IN MESENCHYMAL STEM CELL BY REGION 2017-2025 ($ MILLION)
TABLE 7 GLOBAL STEM CELL MARKET IN NEURAL STEM CELL BY REGION 2017-2025 ($ MILLION)
TABLE 8 GLOBAL STEM CELL MARKET IN DENTAL STEM CELL BY REGION 2017-2025 ($ MILLION)
TABLE 9 GLOBAL STEM CELL MARKET IN UMBILICAL CORD STEM CELL BY REGION 2017-2025 ($ MILLION)
TABLE 10 GLOBAL STEM CELL MARKET IN HUMAN EMBRYONIC STEM CELL BY REGION 2017-2025 ($ MILLION)
TABLE 11 GLOBAL STEM CELLS MARKET IN INDUCED PLURIPOTENT STEM CELL BY REGION 2017-2025 ($ MILLION)
TABLE 12 GLOBAL STEM CELL MARKET IN RAT NEURAL STEM CELL BY REGION 2017-2025 ($ MILLION)
TABLE 13 GLOBAL STEM CELL MARKET BY TECHNOLOGY 2017-2025 ($ MILLION)
TABLE 14 GLOBAL STEM CELL ACQUISITION MARKET 2017-2025 ($ MILLION)
TABLE 15 GLOBAL STEM CELL ACQUISITION MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 16 STEM CELL BONE MARROW MARKET BY REGIONS 2017-2025 ($ MILLION)
TABLE 17 GLOBAL STEM CELL APHERESIS MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 18 GLOBAL STEM CELL UMBLICAL CORD BLOOD MARKET BY REGIONS 2017-2025 ($ MILLION)
TABLE 19 GLOBAL STEM CELL PRODUCTION MARKET 2017-2025 ($ MILLION)
TABLE 20 GLOBAL STEM CELL PRODUCTION MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 21 GLOBAL STEM CELL THERAPEUTIC CLONING MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 22 GLOBAL IVF STEM CELL MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 23 GLOBAL STEM CELL CULTURE MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 24 GLOBAL STEM CELL CRYOPRESERVATION MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 25 GLOBAL STEM CELL EXPANSION AND SUB-CULTURE MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 26 GLOBAL STEM CELLS MARKET BY APPLICATION 2017-2025 ($ MILLION)
TABLE 27 GLOBAL STEM CELLS REGENERATIVE MEDICINE MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 28 NEW CANCER CASES BY SEX, US, 2016
TABLE 29 GLOBAL DRUG DISCOVERY AND DEVELOPMENT MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 30 GLOBAL STEM CELL MARKET BY REGION 2017-2025($ MILLION)
TABLE 31 NORTH AMERICA STEM CELL MARKET 2017-2025 ($ MILLION)
TABLE 32 EUROPE STEM CELL MARKET 2017-2025 ($ MILLION)
TABLE 33 ASIA-PACIFIC STEM CELL MARKET 2017-2025 ($ MILLION)
TABLE 34 INDIAN HEALTH DISORDERS IN 2016 (%)
TABLE 35 ROW STEM CELL MARKET BY REGIONS 2017-2025 ($ MILLION)
FIGURES LIST
FIGURE 1 GLOBAL STEM CELL MARKET 2017-2025 ($ MILLION)
FIGURE 2 GLOBAL STEM CELL MARKET BY REGION 2017-2025 ($ MILLION)
FIGURE 3 KEY FINDINGS OF STEM CELL MARKET
FIGURE 4 AGES OF PEOPLE WITH ALZHEIMER’S DISEASE IN THE UNITED STATES, 2016
FIGURE 5 NIH SPENDING ON STEM CELL RESEARCH BY YEAR 2013-2016 IN USD $BILLION
FIGURE 6 NIH SPENDING ON STEM CELL, BY YEARS (USD BILLIONS)
FIGURE 7 US DISPOSABLE PERSONAL INCOME IN USD BILLIONS
FIGURE 8 GLOBAL STEM CELLS MARKET BY PRODUCTS 2017-2025 ($ MILLION)
FIGURE 9 GLOBAL STEM CELLS MARKET IN ADULT STEM CELL 2017-2025 ($ MILLION)
FIGURE 10 GLOBAL STEM CELL MARKET IN HUMAN EMBRYONIC STEM CELL 2017-2025 ($ MILLION)
FIGURE 11 GLOBAL STEM CELLS MARKET IN INDUCED PLURIPOTENT STEM CELL 2017-2025 ($ MILLION)
FIGURE 12 GLOBAL STEM CELL MARKET IN RAT NEURAL STEM CELL 2017-2025 ($ MILLION)
FIGURE 13 GLOBAL STEM CELL MARKET BY TECHNOLOGY 2017-2025 ($ MILLION)
FIGURE 14 GLOBAL STEM CELL MARKET BY ACQUISITION 2017-2025 ($ MILLION)
FIGURE 15 GLOBAL STEM CELL BONE MARROW MARKET 2017-2025 ($ MILLION)
FIGURE 16 GLOBAL STEM CELL APHERESIS MARKET 2017-2025 ($ MILLION)
FIGURE 17 GLOBAL STEM CELL UMBLICAL CORD BLOOD MARKET 2017-2025 ($ MILLION)
FIGURE 18 GLOBAL STEM CELL PRODUCTION MARKET 2017-2025 ($ MILLION)
FIGURE 19 GLOBAL STEM CELL THERAPEUTIC CLONING MARKET 2017-2025 ($ MILLION)
FIGURE 20 GLOBAL IVF STEM CELL MARKET 2017-2025 ($ MILLION)
FIGURE 21 GLOBAL STEM CELLS CULTURE MARKET 2017-2025 ($ MILLION)
FIGURE 22 GLOBAL STEM CELLS CRYOPRESERVATION MARKET 2017-2025 ($ MILLION)
FIGURE 23 GLOBAL STEM CELL EXPANSION AND SUB-CULTURE MARKET 2017-2025 ($ MILLION)
FIGURE 24 GLOBAL STEM CELLS MARKET BY APPLICATION 2017 & 2025 ($ MILLION)
FIGURE 25 GLOBAL STEM CELLS REGENERATIVE MEDICINE MARKET 2017-2025 ($ MILLION)
FIGURE 26 GLOBAL DRUG DISCOVERY AND DEVELOPMENT MARKET 2017-2025 ($ MILLION)
FIGURE 27 GEOGRAPHIC OUT LOOK 2016 & 2025 (%)
FIGURE 28 TOP GROWING COUNTRIES 2017-2025 ($ MILLION)
FIGURE 29 ESTIMATED NUMBER OF NOVEL CANCER CASES AND DEATHS BY GENDER IN THE U.S., 2016
FIGURE 30 NORTH AMERICA STEM CELL MARKET BY COUNTRIES 2016 & 2025 ($ MILLION)
FIGURE 31 NORTH AMERICA STEM CELL REGIONAL MARKET BREAKDOWN IN 2016 (%)
FIGURE 32 UNITED STATES (U.S.) STEM CELL MARKET 2017-2025 ($ MILLION)
FIGURE 33 ESTIMATED CASES OF CANCER IN CANADA 2015
FIGURE 34 CANADA STEM CELL MARKET 2017-2025 ($ MILLION)
FIGURE 35 EUROPE STEM CELL MARKET 2017-2025 ($ MILLION)
FIGURE 36 EUROPE STEM CELL MARKET REGIONAL OUTLOOK 2016 & 2025 %)
FIGURE 37 UNITED KINGDOM (UK) STEM CELL MARKET 2017-2025 ($ MILLION)
FIGURE 38 FRANCE STEM CELL MARKET 2017-2025 ($ MILLION)
FIGURE 39 AGE STRUCTURE OF GERMANY 2015
FIGURE 40 POPULATION AGED ABOVE 65 YEARS 2005 & 2015 (% OF POPULATION)
FIGURE 41 GERMANY STEM CELL MARKET 2017-2025 ($ MILLION)
FIGURE 42 SPAIN STEM CELL MARKET 2017-2025 ($ MILLION)
FIGURE 43 ITALY STEM CELL MARKET 2017-2025 ($ MILLION)
FIGURE 44 ROE STEM CELL MARKET 2017-2025 ($ MILLION)
FIGURE 45 ASIA-PACIFIC STEM CELL MARKET 2017-2025 ($ MILLION)
FIGURE 46 INDIAN STEM CELL MARKET 2017-2025 ($ MILLION)
FIGURE 47 LUNG CANCER STATISTICS IN CHINA (2010 & 2015)
FIGURE 48CHINA STEM CELL MARKET 2017-2025 ($ MILLION)
FIGURE 49 JAPAN STEM CELL MARKET 2017-2025 ($ MILLION)
FIGURE 50 KOREA STEM CELL MARKET 2017-2025 ($ MILLION)
FIGURE 51 REST OF APAC STEM CELL MARKET 2017-2025 ($ MILLION)
FIGURE 52 LATIN AMERICA STEM CELL MARKET 2017-2025 ($ MILLION)
FIGURE 53 MENA STEM CELL MARKET 2017-2025 ($ MILLION)
FIGURE 54 AFRICA STEM CELL MARKET 2017-2025 ($ MILLION)
FIGURE 55 MARKET SHARE OF ANALYSIS OF KEY PLAYERS 2016 (%)


More Publications